Growth disturbances in children and adolescents receiving long‐term tyrosine kinase inhibitor therapy for Chronic Myeloid Leukaemia or Philadelphia Chromosome‐positive Acute Lymphoblastic Leukaemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2019-05, Vol.185 (4), p.795-799
Hauptverfasser:	Sabnis, Himalee S., Keenum, Caroline, Lewis, Rebecca W., Patterson, Briana, Bergsagel, John, Effinger, Karen E., Silverman, Emily, Mertens, Ann C., Castellino, Sharon M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute lymphoblastic leukemia Adolescent Adolescents Antineoplastic Agents - adverse effects body height Child Child, Preschool Children chronic myeloid leukaemia Chronic myeloid leukemia Enzyme inhibitors Female growth Growth Disorders - chemically induced Hematology Humans Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Male Philadelphia chromosome Philadelphia chromosome‐positive acute lymphoblastic leukaemia Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy protein kinase inhibitors Protein Kinase Inhibitors - adverse effects Retrospective Studies Tyrosine kinase inhibitors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!